Nexviazyme

avalglucosidase alfa-ngpt

Approval

ApplicationBLA 761194
Approval dateAug 6, 2021
Approval year2021
SponsorGenzyme CORP

FDA-approved use

To treat late-onset Pompe disease

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Nexviazyme: